A phase I study of pegylated arginine deiminase ( Pegargiminase), cisplatin, and pemetrexed in argininosuccinate synthetase 1-deficient recurrent high-grade glioma
- Submitting institution
-
Imperial College of Science, Technology and Medicine
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 4308
- Type
- D - Journal article
- DOI
-
10.1158/1078-0432.CCR-18-3729
- Title of journal
- Clinical Cancer Research
- Article number
- -
- First page
- 2708
- Volume
- 25
- Issue
- 9
- ISSN
- 1078-0432
- Open access status
- Not compliant
- Month of publication
- February
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
24
- Research group(s)
-
A - Cancer
- Citation count
- 11
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to carrying out the study, to analysis and interpretation of study data and to the conception and design of the study.
The author helped draft the output and critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -